The Spindle-Assembly Checkpoint and Chromosomal Instability
The spindle-assembly checkpoint (SAC) delays chromosome separation in mitosis until every chromosome is correctly attached to the spindle. When the SAC is weak, chromosomes are distributed unevenly, producing the chromosomal instability seen in many aggressive tumours. Paradoxically, cancer cells still need a working SAC to survive dividing.
Quick Answer
The spindle-assembly checkpoint (SAC) delays chromosome separation in mitosis until every chromosome is correctly attached to the spindle. When the SAC is weak, chromosomes are distributed unevenly, producing the chromosomal instability seen in many aggressive tumours. Paradoxically, cancer cells still need a working SAC to survive dividing.
What the Checkpoint Senses
During mitosis each chromosome must attach to microtubules from opposite spindle poles. Kinetochores that are unattached, or attached without tension, recruit checkpoint proteins and emit a wait signal.
That signal assembles the mitotic checkpoint complex, containing MAD2, BUBR1 (encoded by BUB1B), BUB3 and CDC20, which inhibits the anaphase-promoting complex/cyclosome (APC/C).
How the Signal Is Released
Once every kinetochore is properly attached, the wait signal stops, the APC/C is freed, and it triggers destruction of securin and cyclin B. Loss of securin activates separase, which cleaves the cohesin holding sister chromatids together, and anaphase begins.
Because APC/C activation is essentially irreversible, the checkpoint must be fully satisfied before it happens; a single unattached kinetochore is enough to hold the whole cell.
A Weak Checkpoint and Chromosomal Instability
Reduced SAC strength lets cells enter anaphase before attachments are correct, producing daughter cells with extra or missing chromosomes. Ongoing errors of this kind are termed chromosomal instability (CIN) and are found in most solid tumours.
CIN can accelerate tumour evolution and drug resistance by generating heterogeneity, but excessive missegregation is lethal, giving a window of tolerable instability rather than an all-or-nothing effect.
Why Cancer Cells Still Need the SAC
Complete loss of the SAC causes catastrophic missegregation and death. Studies knocking down BUB1B in breast cancer cells show loss of viability, while normal cells are less affected, suggesting a therapeutic window.
This underlies interest in MPS1/TTK inhibitors and other mitotic-checkpoint drugs, which aim to push an already-unstable tumour past the survivable limit.
Interpretation Notes
SAC-gene expression changes and aneuploidy scores are research metrics; there is no simple one-to-one link between a SAC alteration and a clinical decision.
Constitutional biallelic BUB1B variants cause mosaic variegated aneuploidy syndrome, a rare condition distinct from somatic checkpoint changes in a tumour, and the two should not be conflated.
Key Takeaways
- ·The SAC blocks anaphase until all kinetochores are correctly attached.
- ·A weakened SAC produces chromosomal instability, common in aggressive cancers.
- ·Cancer cells retain a partial SAC and can be vulnerable to further checkpoint inhibition.
- ·SAC metrics are research tools, not standalone clinical guidance.
Put these genes in pathway context
Frequently asked questions
What is the key idea in The Spindle-Assembly Checkpoint and Chromosomal Instability?
The spindle-assembly checkpoint (SAC) delays chromosome separation in mitosis until every chromosome is correctly attached to the spindle. When the SAC is weak, chromosomes are distributed unevenly, producing the chromosomal instability seen in many aggressive tumours. Paradoxically, cancer cells still need a working SAC to survive dividing.
What should be kept with the result or mechanism?
A weakened SAC produces chromosomal instability, common in aggressive cancers. Cancer cells retain a partial SAC and can be vulnerable to further checkpoint inhibition. SAC metrics are research tools, not standalone clinical guidance.
References
- 1The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduction and Targeted Therapy, 2024. PubMed
- 2Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival. Breast Cancer Research and Treatment, 2020. PubMed
- 3The cell cycle, cancer development and therapy. Molecular Biology Reports, 2022. PubMed
- 4Cell cycle control in cancer. Nature Reviews Molecular Cell Biology, 2021. PubMed
Continue Reading
Aurora Kinases in Cancer: Mitotic Regulators as Drug Targets
3 min read
Cell-Cycle Checkpoints Explained: G1/S, Intra-S, G2/M and Mitosis
4 min read
PLK1: A Mitotic Kinase and Its Role in Cancer
3 min read
Clonal Evolution and Genomic Instability in Cancer
4 min read
CCNE1 Amplification and Cyclin E: Biology and Testing Context
3 min read
CDKN2A and MTAP Co-Deletion: Understanding the 9p21 Region
2 min read
Choose your next research step
Move from this explanation into a gene profile, a pathway map, or the next evidence update.
TP53 has 100+ trials currently recruiting on ClinicalTrials.gov. The GeneAnalyses digest summarises the new and changed ones each day.